CVR number 32562205
Industry 21.2000 Manufacture of pharmaceutical preparations

BALANCAIR ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 6.8% 6.4% 2.5%  
Credit score (0-100)  0 0 38 39 63  
Credit rating  N/A N/A BB BB BBB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -159 -433 -234  
EBITDA  0.0 0.0 -163 -480 -2,005  
EBIT  0.0 0.0 -228 -545 -3,587  
Pre-tax profit (PTP)  0.0 0.0 -315.3 -871.2 -3,864.3  
Net earnings  0.0 0.0 -315.3 -871.2 -3,878.2  
Pre-tax profit without non-rec. items  0.0 0.0 -315 -871 -3,864  
 
See the entire income statement

Balance sheet (kDKK) 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Tangible assets total  0.0 0.0 0.0 17.7 957  
Shareholders equity total  0.0 0.0 -583 -1,454 13,478  
Interest-bearing liabilities  0.0 0.0 0.0 114 123  
Balance sheet total (assets)  0.0 0.0 4,397 7,212 16,807  
Net Debt  0.0 0.0 -646 -55.3 -2,397  
 
See the entire balance sheet

Volume 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -159 -433 -234  
Gross profit growth  0.0% 0.0% 0.0% -172.9% 46.0%  
Employees  0 0 2 2 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 50.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 4,397 7,212 16,807  
Balance sheet change%  0.0% 0.0% 0.0% 64.0% 133.1%  
Added value  0.0 0.0 -163.3 -479.8 -2,004.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 2,776 2,998 5,038  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 143.9% 125.8% 1,534.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -4.6% -8.0% -28.2%  
ROI %  0.0% 0.0% -5.0% -8.4% -28.7%  
ROE %  0.0% 0.0% -7.2% -15.0% -37.5%  

Solidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Equity ratio %  0.0% 0.0% -11.7% -16.8% 80.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 395.7% 11.5% 119.6%  
Gearing %  0.0% 0.0% 0.0% -7.9% 0.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 571.5% 234.1%  

Liquidity 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Quick Ratio  0.0 0.0 3.5 4.5 18.4  
Current Ratio  0.0 0.0 3.5 4.5 24.6  
Cash and cash equivalent  0.0 0.0 646.3 169.5 2,519.9  

Capital use efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 1,110.2 1,016.1 4,109.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2014
N/A
2015
N/A
2016
2016/12
2017
2017/12
2018
2018/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -82 -240 -668  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -82 -240 -668  
EBIT / employee  0 0 -114 -272 -1,196  
Net earnings / employee  0 0 -158 -436 -1,293